DNLI — Denali Therapeutics Inc. | XLV Holdings | StockAdder

(DNLI)

Denali Therapeutics Inc.

Live chart and latest DNLI stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

DNLI News

Assessing Denali Therapeutics (DNLI) Valuation After Recent Share Pullback And Pipeline Growth Expectations

Apr 10, 2026 Yahoo Finance

Denali Gains 11.8% in a Month: Buy, Sell or Hold the Stock?

Mar 11, 2026 Gotrade

Denali Therapeutics Inc (DNLI) Stock Price Today & Analysis

Jan 25, 2026 Investing.com

Denali Therapeutics stock maintains Buy rating at Goldman Sachs on pipeline progress

Jan 15, 2026 Seeking Alpha

Denali stock gains on FDA nod for lead asset (DNLI:NASDAQ)

Mar 25, 2026 Stock Titan

Takeda exits dementia drug pact, Denali targets trial data by 2026 end

Apr 3, 2026 simplywall.st

Is It Time To Revisit Denali Therapeutics (DNLI) After Recent Share Price Pullback

Apr 2, 2026 Yahoo Finance

Is Denali Therapeutics (DNLI) the Most Promising Mid-Cap Healthcare Stock Under $50?

Dec 22, 2025 Sahm

How AVLAYAH’s Accelerated Approval and Takeda Exit Will Impact Denali Therapeutics (DNLI) Investors

Apr 9, 2026 Seeking Alpha

Denali Therapeutics Inc. (DNLI) Discusses FDA Approval and Commercial Launch Plans for AVLAYAH for Hunter Syndrome - Slideshow (NASDAQ:DNLI) 2026-03-27

Mar 27, 2026 Stock Titan

Denali Therapeutics (NASDAQ: DNLI) closes $200M royalty deal after FDA OK

Mar 31, 2026 Yahoo Finance

Denali Wins FDA Nod for Hunter Syndrome Drug, Stock Up

Mar 26, 2026 simplywall.st

Have Denali Therapeutics Insiders Been Selling Stock?

Jan 11, 2026 Stock Titan

Vanguard disaggregation: no beneficial DNLI shares reported (DNLI)

Mar 26, 2026 Yahoo Finance

Denali Therapeutics (DNLI): Rethinking Valuation After a 33% One-Month Share Price Rebound